<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//nexcella.com/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://nexcella.com/</loc>
		<lastmod>2026-03-18T18:49:23+00:00</lastmod>
		<image:image>
			<image:loc>https://nexcella.com/wp-content/uploads/2022/11/cropped-cropped-cropped-NEXCELLA-Main-Logo-800x600-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://nexcella.com/wp-content/uploads/2024/10/Nexcella-home-hero-bg-pic.png</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://nexcella.com/wp-content/uploads/2022/11/cropped-cropped-cropped-NEXCELLA-Main-Logo-800x600-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://nexcella.com/wp-content/uploads/2022/11/cropped-cropped-cropped-NEXCELLA-Main-Logo-800x600-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://nexcella.com/wp-content/uploads/2022/11/cropped-cropped-cropped-NEXCELLA-Main-Logo-800x600-1.jpg</image:loc>
		</image:image>
		<image:image>
			<image:loc>https://nexcella.com/wp-content/uploads/2024/09/immx-invest-hero-scaled.jpeg</image:loc>
		</image:image>
	</url>
	<url>
		<loc>https://nexcella.com/expanded-access-policy/</loc>
		<lastmod>2025-08-04T21:51:56+00:00</lastmod>
	</url>
	<url>
		<loc>https://nexcella.com/news/</loc>
		<lastmod>2024-10-02T16:02:01+00:00</lastmod>
	</url>
	<url>
		<loc>https://nexcella.com/publications/</loc>
		<lastmod>2024-04-04T13:17:07+00:00</lastmod>
	</url>
	<url>
		<loc>https://nexcella.com/contact-us/</loc>
		<lastmod>2024-03-29T17:52:13+00:00</lastmod>
	</url>
	<url>
		<loc>https://nexcella.com/nexcella-announces-new-positive-nxc-201-clinical-data-demonstrating-100-complete-responses-in-al-amyloidosis-patients-additional-positive-multiple-myeloma-safety-data-demonstrating-nxc-201-outpatien/</loc>
		<lastmod>2023-03-24T14:58:14+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Rank Math SEO Plugin (c) Rank Math - rankmath.com -->